摘要
Drug resistance is one of the main challenges in cancer treatment. Long non coding RNAs (lncRNAs) play a complex and precise regulatory role in regulating drug resistance of cancer. The common ways of lncRNA regulating drug resistance of cancer involve ATP binding transporter overexpression, abnormal DNA damage response, tumor cell apoptosis, accumulation of epithelial mesenchymal transformation and cancer stem cell formation. Moreover, studies on exosomal lncRNAs regulating cancer drug resistance are developed in recent years. Further study on the role and mechanism of lncRNAs drug resistance in cancer will help clinical cancer treatment program and explore new treatment methods. This paper reviews recent advances in lncRNAs regulating drug resistance of cancer, especially the role of exosomal lncRNAs.
学科与关键词
- Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancerZhang, Hai-Bo; Hu, Yang; Deng, Jun-Li; Fang, Guo-Ying*; Zeng, Ying*Frontiers in Pharmacology, 2023, 14: 1243934.被引 1
- Non-coding RNAs as Novel Biomarkers in Cancer Drug ResistanceYang, Haixiu; Qi, Changlu; Li, Boyan; Cheng, Liang*Current Medicinal Chemistry, 2022, 29(5): 837-848.被引 10
- The regulatory mechanisms of long noncoding RNAs and their role in cancerBin YAN; YiQun JIANG; Ya CAO; YongGuang TAOChinese Science Bulletin (Chinese Version), 2012, 57(36): 3467.
